{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:30:25Z","timestamp":1787729425389,"version":"build-2784847793"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,3]]},"DOI":"10.7759\/cureus.85295","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:03:27Z","timestamp":1748970207000},"source":"Crossref","is-referenced-by-count":1,"title":["Atypical Femoral Fracture Following Long-Term Bisphosphonate Therapy: An Uncommon Complication of a Common Treatment"],"prefix":"10.7759","author":[{"given":"Diogo","family":"Ribeiro de Sene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.85a.17119","article-title":"Bisphosphonate-related atypical femoral fracture: managing a rare but serious complication","volume":"85","author":"Silverman S","year":"2018","unstructured":"Silverman S, Kupperman E, Bukata S. Bisphosphonate-related atypical femoral fracture: managing a rare but serious complication. Cleve Clin J Med. 2018, 85:885-93. 10.3949\/ccjm.85a.17119","journal-title":"Cleve Clin J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3109\/17453674.2013.859423","article-title":"Denosumab and atypical femoral fractures","volume":"85","author":"Aspenberg P","year":"2014","unstructured":"Aspenberg P. Denosumab and atypical femoral fractures. Acta Orthop. 2014, 85:1. 10.3109\/17453674.2013.859423","journal-title":"Acta Orthop"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/17453674.2015.1004149","article-title":"Risk of atypical femoral fracture during and after bisphosphonate use","volume":"86","author":"Schilcher J","year":"2015","unstructured":"Schilcher J, Koeppen V, Aspenberg P, Micha\u00eblsson K. Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop. 2015, 86:100-7. 10.3109\/17453674.2015.1004149","journal-title":"Acta Orthop"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37944-x","article-title":"Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system","volume":"13","author":"Xiao Y","year":"2023","unstructured":"Xiao Y, Chen Y, Huang Y, Xiao Y. Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system. Sci Rep. 2023, 13:10892. 10.1038\/s41598-023-37944-x","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/14782715241301487","article-title":"Atypical femur fracture following romosozumab and bisphosphonate treatment","volume":"55","author":"Jacunski M","year":"2025","unstructured":"Jacunski M, Johnsson H, Ralston SH, Hauser B. Atypical femur fracture following romosozumab and bisphosphonate treatment. J R Coll Physicians Edinb. 2025, 55:19-22. 10.1177\/14782715241301487","journal-title":"J R Coll Physicians Edinb"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz295","article-title":"Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue Society","volume":"105","author":"van de Laarschot DM","year":"2020","unstructured":"van de Laarschot DM, McKenna MJ, Abrahamsen B, et al.. Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue Society. J Clin Endocrinol Metab. 2020, 105:1682-99. 10.1210\/clinem\/dgz295","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/366765-atypical-femoral-fracture-following-long-term-bisphosphonate-therapy-an-uncommon-complication-of-a-common-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:03:27Z","timestamp":1748970207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/366765-atypical-femoral-fracture-following-long-term-bisphosphonate-therapy-an-uncommon-complication-of-a-common-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.85295","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}